New research from the University of British Columbia suggests that commonly used stimulants—such as caffeine and amphetamines—can have opposite effects depending on a person’s baseline motivation: they may boost effort in disengaged individuals but reduce willingness to work in those who are already highly motivated.
The study, published in Nature’s Neuropsychopharmacology, examined how stimulants influence decision-making about cognitive effort by comparing two groups of rats: those that habitually avoided difficult tasks (“slackers”) and those that routinely chose more demanding options for greater rewards (“workers”). The findings illuminate why stimulants affect individuals differently and highlight the potential value of tailoring stimulant-based treatments for people with a variety of medical and psychiatric conditions.
Key findings: stimulants change effort allocation depending on baseline motivation
Researchers led by Jay Hosking, a PhD candidate in UBC’s Department of Psychology, report that stimulants did not produce a uniform increase in effort. Instead, amphetamine increased task engagement in rats that typically avoided challenging choices, making these “slacker” animals more likely to work for a reward. Conversely, rats that normally accepted higher-effort options to obtain larger rewards were less inclined to choose difficult tasks when given caffeine or amphetamine. In short, stimulants improved performance among less motivated animals but tended to reduce effort among animals already predisposed to take on difficult tasks.
These outcomes suggest that the effects of stimulant drugs on cognition and motivation are mediated by an individual’s baseline willingness to exert cognitive effort. While the underlying neural mechanisms remain to be fully elucidated, the study points to baseline cognitive differences as an important factor that may predict whether a stimulant will enhance or impair performance on effortful tasks.
Why this matters: implications for clinical use and everyday stimulant use
Millions of people rely on stimulants—ranging from coffee and energy drinks to prescription amphetamines—to stay alert and improve productivity, whether working late shifts or preparing for exams. The UBC study urges caution and nuance: stimulants do not universally increase motivation and may even have counterproductive effects for individuals who are already highly engaged or willing to take on mentally demanding work.
Catharine Winstanley, a co-author and professor in UBC’s Department of Psychology, emphasizes that people with psychiatric disorders, brain injuries, or Attention Deficit Hyperactivity Disorder (ADHD) often use stimulants to combat fatigue and drowsiness associated with their conditions or treatments. The mixed responses observed in the study suggest that treatment programs could achieve better outcomes by taking individual differences in baseline cognitive effort into greater account when prescribing or recommending stimulants.
Research context and future directions
The experiments used a novel rodent cost/benefit decision-making task to measure how much effort animals were willing to expend for a given reward, then assessed how stimulant drugs altered those choices. Although further research is needed to pinpoint the exact neural circuits and neurotransmitter systems involved, the current findings add an important behavioral dimension to our understanding of stimulant effects and motivate additional studies aimed at individualized approaches to cognitive-enhancing therapies.
In clinical terms, the results underscore the potential value of personalized treatment strategies. Rather than assuming stimulants will uniformly boost attention and productivity, clinicians and patients may benefit from evaluating baseline motivational tendencies and cognitive profiles to predict who will gain versus who may experience diminished willingness to work under stimulant influence.
Overall, the UBC study advances an important message: stimulants can be beneficial for some individuals and detrimental for others depending on pre-existing levels of motivation and the willingness to engage in effortful mental activity. Recognizing these individual differences could improve therapeutic decisions and everyday use of stimulants, reducing unintended decreases in performance among those who are already predisposed to high effort.
Notes about this neuroscience research article
Contacts: Basil Waugh – UBC Public Affairs
Jay Hosking – UBC Psychology
Source: University of British Columbia press release
Original Research: Abstract for “Sensitivity to Cognitive Effort Mediates Psychostimulant Effects on a Novel Rodent Cost/Benefit Decision-Making Task” by Paul J Cocker, Jay G Hosking, James Benoit and Catharine A Winstanley in Neuropsychopharmacology advance online publication, March 28, 2012; doi:10.1038/npp.2012.30